The rationale behind neoadjuvant therapy in HER2-positive breast cancer, as well as an overview of commonly used treatment regimens.
Website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]
![](https://i.ytimg.com/vi/r3CYfkq7KjU/maxresdefault.jpg)
The rationale behind neoadjuvant therapy in HER2-positive breast cancer, as well as an overview of commonly used treatment regimens.
Website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]